These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28591415)

  • 41. Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.
    Hsi ED
    Leuk Lymphoma; 2008 Sep; 49(9):1668-80. PubMed ID: 18798102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomic analyses of microdissected Hodgkin and Reed-Sternberg cells: mutations in epigenetic regulators and p53 are frequent in refractory classic Hodgkin lymphoma.
    Mata E; Fernández S; Astudillo A; Fernández R; García-Cosío M; Sánchez-Beato M; Provencio M; Estévez M; Montalbán C; Piris MA; García JF
    Blood Cancer J; 2019 Mar; 9(3):34. PubMed ID: 30858359
    [No Abstract]   [Full Text] [Related]  

  • 43. Primary cutaneous follicle center lymphoma with Hodgkin and Reed-Sternberg-like cells: a new histopathologic variant.
    Dilly M; Ben-Rejeb H; Vergier B; Feldis M; Toty L; Nohra O; Beylot-Barry M; Gros A; Merlio JP; Parrens M
    J Cutan Pathol; 2014 Oct; 41(10):797-801. PubMed ID: 25099172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
    Kelly KM
    Blood; 2015 Nov; 126(22):2452-8. PubMed ID: 26582374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Macrophages predict treatment outcome in Hodgkin's lymphoma.
    Steidl C; Farinha P; Gascoyne RD
    Haematologica; 2011 Feb; 96(2):186-9. PubMed ID: 21282720
    [No Abstract]   [Full Text] [Related]  

  • 46. Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
    Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Aoun P; Bello CM; Benitez CM; Bernat K; Bierman PJ; Blum KA; Chen R; Dabaja B; Forero A; Gordon LI; Hernandez-Ilizaliturri FJ; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Maloney DG; Mauch PM; Metzger M; Moore JO; Morgan D; Moskowitz CH; Mulroney C; Poppe M; Rabinovitch R; Seropian S; Smith M; Winter JN; Yahalom J; Burns J; Ogba N; Sundar H
    J Natl Compr Canc Netw; 2017 May; 15(5):608-638. PubMed ID: 28476741
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Expression of BSAP/CD30 in classic Hodgkin lymphoma using double-staining technique].
    Xi YF; Bai WQ; Wang JF; Wang QH; Jiao SL
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):136-7. PubMed ID: 17493393
    [No Abstract]   [Full Text] [Related]  

  • 48. CD68 staining correlates with the size of residual mass but not with survival in classical Hodgkin lymphoma.
    Agur A; Amir G; Paltiel O; Klein M; Dann EJ; Goldschmidt H; Goldschmidt N
    Leuk Lymphoma; 2015 May; 56(5):1315-9. PubMed ID: 25204373
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anaplastic variant of diffuse large B-cell lymphoma: Reappraisal as a nodal disease with sinusoidal involvement.
    Megahed NA; Kohno K; Sakakibara A; Eladl AE; Elsayed AA; Wu CC; Suzuki Y; Takahara T; Kato S; Nakamura S; Satou A; Asano N
    Pathol Int; 2019 Dec; 69(12):697-705. PubMed ID: 31872533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hodgkin lymphoma.
    Nat Rev Dis Primers; 2020 Jul; 6(1):62. PubMed ID: 32703949
    [No Abstract]   [Full Text] [Related]  

  • 51. Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma.
    Kostakoglu L
    Eur J Nucl Med Mol Imaging; 2008 Aug; 35(8):1413-20. PubMed ID: 18385996
    [No Abstract]   [Full Text] [Related]  

  • 52. Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma.
    Kamper P; Ludvigsen M; Bendix K; Hamilton-Dutoit S; Rabinovich GA; Møller MB; Nyengaard JR; Honoré B; d'Amore F
    Blood; 2011 Jun; 117(24):6638-49. PubMed ID: 21505194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The translational science of hodgkin lymphoma.
    Cirillo M; Reinke S; Klapper W; Borchmann S
    Br J Haematol; 2019 Jan; 184(1):30-44. PubMed ID: 30417946
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modern treatment of Hodgkin lymphoma.
    Bartlett NL
    Curr Opin Hematol; 2008 Jul; 15(4):408-14. PubMed ID: 18536581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. I. Hodgkin lymphoma: special challenges and solutions.
    Connors JM
    Hematol Oncol; 2015 Jun; 33 Suppl 1():21-4. PubMed ID: 26062048
    [No Abstract]   [Full Text] [Related]  

  • 56. Expression of COX-2 on Reed-Sternberg cells is an independent unfavorable prognostic factor in Hodgkin lymphoma treated with ABVD.
    Mestre F; Gutierrez A; Ramos R; Martinez-Serra J; Sánchez L; Matheu G; Ros T; Garcia JF; Rodriguez J
    Blood; 2012 Jun; 119(25):6072-9. PubMed ID: 22547578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy Selection for Hodgkin Lymphoma in Sickle Cell Disease: balancing risks and benefits.
    Fraley CE; McKinney C; Nuss R; Franklin ARK
    Blood Adv; 2023 May; 7(10):2042-2046. PubMed ID: 36459497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic utility of programmed cell death ligand 1 (clone SP142) in mediastinal composite lymphoma: A report of two cases.
    Sakakibara A; Kohno K; Iwakoshi A; Moritani S; Fujishiro A; Kito K; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Takahashi E; Ohashi A; Satou A; Kato S; Asano N; Nakamura S
    Pathol Int; 2020 Feb; 70(2):116-122. PubMed ID: 31894883
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absolute monocyte count at diagnosis could improve the prognostic role of early FDG-PET in classical Hodgkin lymphoma patients.
    Bari A; Marcheselli L; Marcheselli R; Pozzi S; Cox MC; Baldessari C; Ferri P; Gobbi P; Baldini L; Tadmor T; Musto P; Federico M; Sacchi S
    Br J Haematol; 2018 Feb; 180(4):600-602. PubMed ID: 27785782
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of Newly Diagnosed Classical Hodgkin Lymphoma.
    Straus DJ
    Clin Lymphoma Myeloma Leuk; 2020 Sep; 20 Suppl 1():S87-S88. PubMed ID: 32862883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.